The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)
Abstract
Background Effective treatment requires regular follow-up and monitoring of symptoms. We investigated sensitivity to change and minimal clinically important difference of the Generalized Anxiety Disorder Scale (GAD-7).Methods This study included all participants from a multisite trial of chronic depression. Baseline and follow-up (12 and 48 weeks) data were used to assess treatment response. Effect sizes (ES) and standardized response means (SRM) of pre- and post-GAD-7 mean changes were calculated for subgroups of patients, who did or did not improve according to ratings in the Hamilton Rating Scale for Depression (HRSD-24).Results N = 261 patients were included in the analyses. In the subgroup of patients who improved according to HRSD-24, GAD-7 scores were significantly lower after 12 weeks (t = -6.31, df = 120, p < .001; ES = -0.51, SRM = -0.57), and 48 weeks of treatment (t = -12.68, df = 141, p < .001; ES = -1.0, SRM = -1.7), when compared to admission. In the group who worsened, GAD-7 scores were significantly higher after 12 weeks (t = 2.96, df = 41, p = .005; ES = 0.30, SRM = 0.46), and increased after 48 weeks (t = 1.99, df = 21, p = .059; ES = 0.37, SRM = 0.43), when compared to baseline. The unchanged group showed no significant difference between baseline and follow-up. MCID was estimated 4 points on the GAD-7 total score.Limitations Confirmation of these findings and further investigation of the GAD-7 in populations and trials focusing on anxiety-specific treatment is highly recommended.Conclusions Results show that the GAD-7 is sensitive to detect change in psychopathology over the course of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The minimal clinically important difference for GAD-7 was 3.8; the clinically relevant change was ≥4 points [51].”
From Clinical Efficacy and Psychological Mechanisms of an App-Based Digital Therapeutic for Generalized Anxiety Disorder: Randomized Controlled Trial (2021) · cites this paper as [51]
In the citing paper
“This change met the level of minimal clinical important difference (MCID), which is estimated at 4 points on the GAD-7 total score [30].”
From The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review (2022) · cites this paper as [30]
In the citing paper
“which is estimated at 4 points on the GAD-7 total score [30].”
From The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review (2022) · cites this paper as [30]
In the citing paper
“Anxiety will be measured with the 7-item Generalized Anxiety Disorder Scale (GAD-7; range, 0–21; higher scores indicate greater severity) [25].”
In the citing paper
“As noted above, we observed clinically meaningful improvements in both anxiety and depression, with reductions in GAD-7 (− 5.04) and PHQ-9 (− 5.64) higher than the MCID for both conditions (3.8 and 5, respectively) [66, 67].”
From Telerehabilitation of acute musculoskeletal multi-disorders: prospective, single-arm, interventional study (2022) · cites this paper as [66]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Self-citationKessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Lakens, D. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00863 · Cited by 10,303
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- First, 2002, Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P)
- Schuck, 2000, Z. Med. Psychol, 9, 125
Cited by
Sorted by citations
Items 501–600 of 638
Levey, N., Bakhshaie, J., Vranceanu, A., & Greenberg, J. (2025) · Journal of Integrative and Complementary Medicine · doi:10.1177/27683605251363177
Ma, C.-C., Yang, C.-Y., Chang, W., Sack, A. T., Chang, C.-C., & Chang, H. (2025) · Medicina · doi:10.3390/medicina61091522
“The self-reported overall severity of depression and anxiety was assessed using the Patient Health Questionnaire (PHQ-9) [32], and Generalized Anxiety Disorder 7 (GAD-7) [33], respectively.”
Greenaway, A.-M., Hwang, F., Nasuto, S. J., & Ho, A. K. (2025) · Psychological Reports · doi:10.1177/00332941251370235
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome
Evans, L., Erridge, S., Varadpande, M., Aggarwal, A., Cowley, I., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70823
Aagesen, M., Pilegaard, M. S., Ipsen, K., Jørgensen, D. S., Hauken, M. A., & la Cour, K. (2025) · Journal of Adolescent and Young Adult Oncology · doi:10.1177/21565333251372461
A Mixed-Methods Analysis of Response to NOVELA Among Hospice Family Caregivers
Cruz-Oliver, D. M., Blinka, M. D., Milner, G. E., Nelson, K. E., Bugayong, M. T., Durkin, N., Gallo, J. J., Oliver, D. P., & Saylor, M. A. (2025) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091251371149
“11,31 Lastly, the sample was largely homogenous, comprised of White females, which was a recruitment limitation and decreased our ability to generalize results.”
Kumar, D., Kumar, D., Sharma, N., Kumar, R., Rastogi, D., & Alim, M. (2025) · Tropical Doctor · doi:10.1177/00494755251376420
“18 22 In our study, signi fi cant anxiety in children with epilepsy was found in 8%, implying epilepsy may not be a contributory factor.”
A reason for caution: the identification of sudden gains may depend on the outcome measure used
Correa, A. B., Bisby, M. A., & Dear, B. F. (2025) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2025.2556723
“A large meta-analysis (Plummer et al., 2016) identified a score of � 8 to be a reasonable cutoff for clinical levels of anxiety, and a change of 4-points has been identified as clinically meaningful (Toussaint et al., 2020).”
Routhier, G., Titus, A. R., Xin, Y., Cui, B., & Cook, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-24535-w
“The GAD-7 is a validated self-report screening tool that measures symptoms of anxiety, with scores ranging from 0 to 21 [21].”
Þórarinsdóttir, K., Holmes, E. A., Hardarson, J., Ágústsdóttir, F., Kanstrup, M., Singh, L., Hauksdóttir, A., Halldorsdottir, T., Guðmundsdóttir, B., Thordardottir, E. B., et al. (2025) · JMIR Formative Research · doi:10.2196/72748
“A 4-point change on the GAD-7 from pre-to posttreatment is considered clinically significant [42].”
Wu, J., Min, J., Luo, Y., Li, P., Li, L., Ge, Y., Yun, Y., Lei, C., Wang, Q., Zhou, F., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101561
“Generalised Anxiety Scale (GAD-7) 33 : This is used to assess the severity of anxiety symptoms in the 2 weeks preceding the patient interview; each item is scored on a 4-point scale from ‘not at all’ to ‘almost every day’.”
InfluentialExamining the effectiveness and equity of fully virtual therapy for college students
Loren, D. M., Reuter, T., Palko, A., Bickham, N., Klein, K. V., & Booth, R. (2025) · Journal of American College Health · doi:10.1080/07448481.2025.2563025 · Cited by 2
“We used standard clinical assessments (GAD-7, PHQ-9) to monitor patients’ self-reported anxiety and depression symptoms.”
Davies, L., Dusic, A., Adam, A. E., Khan, K. W., Dol, D., Leonardo, X., Ram, K., Tromp, V., Acosta, J., Ahmed, F., et al. (2025) · Open Journal of Internal Medicine · doi:10.4236/ojim.2025.154026
Lucas, L. S., Borba, B. L. I., de Azevedo, B. M., Cagliari, A., Valim, A. R. D. M., Garcia, E. L., Areosa, S. V. C., Morelle, A. M., Damin, M. R. A., Stülp, S., et al. (2025) · General Psychiatry · doi:10.1136/gpsych-2025-102067 · Cited by 1
Analysis of clinical application value of miR-1284 in type 2 diabetes mellitus
Li, Y., Yang, Y., Ma, Y., & Yan, L. (2025) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2025-0123
“After caring, the patient health questionnaire-9 (PHQ-9) and generalized anxiety disorder-7 (GAD-7) were used for scoring, with higher scores indicating more severe depression or anxiety [27, 28].”
Chang, C.-H., Sack, A. T., Chu, C., & Chang, H. (2025) · medRxiv · doi:10.1101/2025.10.30.25339032
“The self - reported overall severity of depression and anxiety was assessed using the Patient Health Questionnaire (PHQ - 9)(Chung et al., 2023), and Generalized Anxiety Disorder 7 (GAD - 7)(Toussaint et al., 2020), respectively.”
Ballester, L., Gili, M., Roca, M., Forteza-Rey, I., Soto‐Sanz, V., Vilagut, G., Amigo, F., Moreno‐Küstner, B., Mortier, P., Piqueras, J. A., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-24752-3 · Cited by 2
“For GAD-7, 4 points were estimated as the minimal clinically important difference in longitudinal assessments and corresponding to two standard error of measurement [63].”
Yanagi, N., Katsuta, N., Nojiri, S., Nara, T., Kumamaru, K. K., Takeshita, Y., & Tobita, M. (2025) · medRxiv · doi:10.1101/2025.11.06.25339711
Wang, L., Peng, Y., Zhang, G., Huang, Y., Yang, G., Yu, J., Xu, Q., Yu, J., Jin, J., Qiao, H., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/68573
“The GAD-7 scale consists of 7 items that assess the anxiety levels of participants over the past 2 weeks, with higher scores indicating greater anxiety (0 ‐ 21 points) [28,29].”
Kern, D., Ljótsson, B., Catrina, S., Lindefors, N., & Kraepelien, M. (2025) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2025.2595107
Goozeé, S., Crane, J., Giertych, A., Maoz, I., Johnson, M., Luong, A., & Navani, A. H. (2025) · Journal of Aggression Maltreatment & Trauma · doi:10.1080/10926771.2025.2585259
“Total score ranges from 0 to 21, with 0–4 indicating minimal anxiety, 5–9 indicating mild anxiety, 10–14 indicating moderate anxiety, and 15–21 indicating severe anxiety (Toussaint et al., 2020).”
Metivier, A., Chrusciel, T., Miller-Matero, L. R., Salas, J., Pappas, C., Secrest, S., Wilson, L., Lustman, P. J., Ahmedani, B. K., Carpenter, R. W., et al. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.11.010
Zhang, H., Li, Y., Wang, C., Liu, Y., Yang, Y., Zhou, L., Jin, H. M., Xiao, Y., Wen, Y., Ahmad, J., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1680558
Clare, A., Mukumba, R., Mclaren, M., Dalal, N., Murray, J., Wayal, S., & Hollowell, J. (2025) · Mental Health Science · doi:10.1002/mhs2.70035
Residual Income and Mental Health: A Longitudinal Study
Korbel, V., & Škvrňák, M. (2025) · Social Indicators Research · doi:10.1007/s11205-025-03742-3
“The minimal clinically important difference (MCID) for depression and anxiety scales has been identified as approximately 3 to 5 points (Kroenke et al., 2001; Toussaint et al., 2020).”
Yao, Y., Liu, S., Jin, L., Ye, J. L., Fang, Z. Y., Yang, Y., Xu, L., Cai, B., & Jiang, X. H. (2025) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70261
“The total scores were graded as no anxiety (0–4 points), mild anxiety (5–9 points), moderate anxiety (10–14 points), or severe anxiety (15–21 points) (Toussaint et al. 2020).”
Mao, P., Xia, J., Yang, J., Hou, X., Zou, Y., Liu, J., Cai, L., Tong, X., & He, W. (2025) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2025.107842
Bakal, M., Ambriz, E., Ortiz-Pivaral, L., Kogut, K., Snell‐Rood, C., Rauch, S. A., Eskenazi, B., & Deardorff, J. (2024) · Figshare · doi:10.6084/m9.figshare.26755684
Singh, K., Kondal, D., Mohan, S., Jaganathan, S., Deepa, M., Venkateshmurthy, N. S., Jarhyan, P., Anjana, R. M., Narayan, K. M. V., Mohan, V., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14391486
Powell, S. K., Saali, A., Frere, J. J., Magill, E. B., Krystal, H. L., Serafini, R. A., Sultana, S., Dale, B., Ali, M., Kumar, V., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381875
Bakal, M., Ambriz, E., Ortiz-Pivaral, L., Kogut, K., Snell‐Rood, C., Rauch, S. A., Eskenazi, B., & Deardorff, J. (2024) · Figshare · doi:10.6084/m9.figshare.26755681
Singh, K., Kondal, D., Mohan, S., Jaganathan, S., Deepa, M., Venkateshmurthy, N. S., Jarhyan, P., Anjana, R. M., Narayan, K. M. V., Mohan, V., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14391483
Wen, Y., Xiong, L., Luo, S., Deng, G., Jiang, J., & Li, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4008731/v1
Powell, S. K., Saali, A., Frere, J. J., Magill, E. B., Krystal, H. L., Serafini, R. A., Sultana, S., Dale, B., Ali, M. O., Kumar, V., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381872
Murea, M., Highland, B. R., Yang, W. Z., Dressler, E. V. M., & Russell, G. B. (2022) · Figshare · doi:10.6084/m9.figshare.21220406
Murea, M., Highland, B. R., Yang, W. Z., Dressler, E. V. M., & Russell, G. B. (2022) · Figshare · doi:10.6084/m9.figshare.21220409
Wang, J., Luo, Y., Yan, N., Wang, Y., Shiferaw, B. D., Tang, J., Pei, Y., Chen, Q., Zhu, Y., & Wang, W. (2023) · Figshare · doi:10.6084/m9.figshare.23658111
Almarri, F. K., Alaseem, A. M., Alanazi, M. S., Alyahya, S., Alsanad, N. H., Alswayed, K. E., Alanazi, J., Alharby, T. N., & Alghamdi, S. A. (2022) · Figshare · doi:10.6084/m9.figshare.21557567
Mikkonen, J., Luomajoki, H., Airaksinen, O., Goubert, L., & Leinonen, V. (2023) · Figshare · doi:10.6084/m9.figshare.22774246
Chiauzzi, E. J., Williams, A. A. A., Mariano, T. Y., Pajarito, S., Robinson, A. H., Kirvin-Quamme, A., & Forman‐Hoffman, V. L. (2024) · Figshare · doi:10.6084/m9.figshare.26674502
Mikkonen, J., Luomajoki, H., Airaksinen, O., Goubert, L., & Leinonen, V. (2023) · Figshare · doi:10.6084/m9.figshare.22774252
Wu, J., Huang, Z., Chen, Y., Chen, Y., Pan, Z., & Gu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16880341
Mikkonen, J., Luomajoki, H., Airaksinen, O., Goubert, L., & Leinonen, V. (2023) · Figshare · doi:10.6084/m9.figshare.22774249
Du, J., Wang, J., Zhang, L., Liu, M., Nie, Y., Zhang, W., He, Y., Wu, Q., Liu, Y., Ai, S., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120980
Zhan, X., Zeng, J., Zhu, D., Chen, Y., Zhang, J., Li, S., & Huang, L. (2026) · Journal of Visualized Experiments · doi:10.3791/69949
Gaming‑Based Community Intervention for Loneliness in Adult Gamers: Longitudinal Observational Study
Neu, C., Hull, T. D., & Malgaroli, M. (2026) · JMIR Formative Research · doi:10.2196/82428
“The GAD-7 was also selected for its length, reliability, validity, and sensitivity to change [69].”
Berkowitz, J. L., Lu, F. Q., DeAngelis, J., Simmons, J. M. D., & Wu, W.-C. (2026) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000997
Wu, C., Haicui, S. H. E. N., Zhou, J., & Wang, J. (2026) · Psycho-Oncologie · doi:10.18282/po4128
Moon, K. J., Burgette, L. F., Choi, J., Nameth, K., Shah, K., Watkins, K. E., & Osilla, K. C. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113053
Cutting, T., & Hartman, R. E. (2026) · Medicine Advances · doi:10.1002/med4.70051
“Treatment with ( R, S )‐ketamine occurred once per week, and study participants were evaluated after 2 and 4 weeks using the Patient Health Questionnaire‐9 [58] to measure depressive symptoms and the Generalized Anxiety Disorder 7‐item scale [59] to assess anxiety.”
Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”
Otsubo, T., Watanabe, K., Inoue, T., Inagaki, A., Kikuchi, T., Nomoto, K., Higa, S., Asami, Y., Sun, B., & Marschall, K. (2026) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.70027
Howard, L. R., Earleywine, M., DeCount, T., & Forsyth, J. P. (2026) · Clinical Case Studies · doi:10.1177/15346501261421541
“Her pre-treatment score of 15 decreased by 10 points, which is above the minimal clinically important difference (MCID) of 4 points (Toussaint et al., 2020).”
Cracas, S. V., Garro, G., Venetucci, J., Martorana, M., Antona, A., Bettio, V., Rossato, D., Briacca, L., Viola, E., Caristia, S., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109328
“22 The ability to deal with stressful situations was measured with the Perceived Stress Scale-10, 23 while coping strategies were evaluated using the 21-item Coping Inventory for Stressful Situations, which captures task-oriented, emotion-oriented and avoidance-oriented coping styles.”
Curry, G., Zhang, S.-D., McAnena, L. B., Price, R. K., & Sittlington, J. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.11.008
Zhang, L., Peng, Z., Cheng, P., Zheng, W., Xu, L., & Li, W. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-102149
Gould, R. L., Callaghan, T., White, D., Wetherell, J. L., Bursnall, M., Bradburn, M., Wailoo, A., Serfaty, M. A., Graham, C. D., Howard, R. J., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07094-6
“…of 0.37 SD is based on the fact that: a) improvements of 3–4 GAD-7 units are regarded as clinically important changes to individual patients [36– 39]; and b) a change of approximately 2 GAD-7 units (0.4 SD) would mean an additional 15% of people having a clinically important improvement of 3…”
InfluentialShi, Y., Zeng, P., Fan, X., Wang, L., He, C., Zhou, Z., Deng, W., Guo, J., Zhang, Y., Luo, Y., et al. (2026) · Nature and Science of Sleep · doi:10.2147/nss.s571703
McAlister, K. L., Baez, L. M., Newton, D. A., Seiniger, S., Woodhouse, A., & Huberty, J. (2026) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580261418135
“30 Symptoms of anxiety are assessed using the GAD-7, 31 a 7-item self-report measure of the severity of generalized anxiety symptoms over the last 2 weeks.”
Sleep Disturbances and Mental Health Outcomes in Chinese Youth Following COVID-19 Policy Changes
Caldwell, P. N., & Reynolds, B. S. (2021) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/zq17uchdr0
Dai, C., Hu, Y., Huang, M., Liu, X., Tao, Z., Zhang, X., Li, X., Yang, X., 叶梦茜, Fu, F., et al. (2026) · Neuroradiology · doi:10.1007/s00234-026-03906-z
“Sleep quality and insomnia severity were subjectively assessed with Pittsburgh Sleep Quality Index (PSQI) [26 ], while depression and anxiety symptoms were measured with the Patient Health Questionnaire-9 (PHQ-9) [26 ]and the Generalized Anxiety Disorder-7 (GAD-7) [27 , 28 ], respectively.”
Cognitive bias modification for social anxiety: a living systematic review and network meta-analysis
Kennett, J., Chiocchia, V., Friedrich, C., Blackwell, S. E., Carlbring, P., Furukawa, T. A., Siafis, S., Money, C., Tonia, T., Wright, S. L., et al. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25609.1
Pembroke, L., Sherman, K. A., Dhillon, H. M., Francis, H., Gillatt, D. A., & Gurney, H. (2026) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2026.2637569
Helminen, E.-E., Saarni, S. E., Mikkonen, K., Mattila, M. K., Rosenström, T. H., Karukivi, M., Isometsä, E. T., Stenberg, J., Ekelund, J., & Saarni, S. I. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07962-w
“…proportion of patients in remission [32, 36], defined as scoring below the clinical cut-off ( 10 p in PHQ-9 or GAD-7 respectively), and those experiencing a clinically significant change in depression symptoms, indicated by a change of ≥ 5 [60] points on the PHQ-9 or ≥ 4 points on the GAD-7 [61].”
Intensity of physical activity, VO₂max, and mental health in women: Does motherhood matter?
Vallini, L., Souza, V. R. D. A., Vivan, L., de Lira, C. A. B., de Freitas, J. V. R., Costa, G. D. C. T., Vancini, R. L., Weiss, K., Rosemann, T. J., Knechtle, B., et al. (2026) · Acta Psychologica · doi:10.1016/j.actpsy.2026.106630
Neuroanatomical Substrates of emotional Dysregulation in Bulimia NervosaPreprint
Zhang, L., Zhao, X., Liu, L., Bao, W., Wang, M., Wang, Y., Hu, X., & Huang, X. (2026) · Research Square · doi:10.21203/rs.3.rs-9025261/v1
Feasibility of classic massage for Swedish nurses: a mixed methods pre-post-test design study
Westas, M., Ekström, L., Sandqvist, J. L., Wåhlin, C., Andersson, G., & Johansson, P. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-026-05356-9
“A 4-point reduction has been suggested as the threshold for minimum clinically important difference (MCID) [27].”
Eyles, E., Farr, M., Dunn, B. D., Redaniel, M. T., Warbrick, L. A., Kessler, D. S., Cooper, R., & Moran, P. (2026) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x25100482
“(2) Anxiety symptoms (General Anxiety Disorder-7, GAD-7) (Toussaint et al ., 2020); higher scores (ranging between 0 and 21) indicate more severe anxiety.”
Pawluk, A., Ward, G., & Niyyati, S. (2026) · BMC Family Practice · doi:10.21203/rs.3.rs-9034659/v1
Ukpeh, P., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., Khan, S. A., & Sodergren, M. H. (2026) · Progress in Palliative Care · doi:10.1080/09699260.2026.2650901
Nishijima, D. K., Kuppermann, N., Suskauer, S. J., Arbogast, K. B., Badawy, M. K., Casper, T. C., Cruz, A. T., Corwin, D. J., Johnson, T. J., Rosenthal, E. D., et al. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06788-5 · Cited by 3
“A change of 4 points on the GAD-7 is the minimal clinically important difference [34].”
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine
Hooper, L., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Iqbal, A., Rucker, J., Weatherall, M. W., & Sodergren, M. H. (2026) · Brain and Behavior · doi:10.1002/brb3.71323
“Scores are totalled as follows: 0–4: minimal anxiety, 5–9: mild anxiety, 10–14: moderate anxiety, 15–21: severe anxiety 0–21 4-point change (Toussaint et al. 2020 )”
Matlock, S., Birmingham, D., Merritt, T., Hess, A., Reega, S. J., & Peters, B. (2026) · Journal of Experiential Education · doi:10.1177/10538259261440175
“The GAD-7 has evidence of construct validity, excellent reliability, and is sensitive to change with intervention (Löwe et al., 2008; Williams, 2014a; Toussaint et al., 2020).”
Chong, Y. Y., Chan, J. K. F., Yau, P. T., Li, T. M. H., Fung, K. P., & Chien, W. T. (2026) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2026.105525
Puteikis, K., Aukselė, G., Jakonienė, A., Jasionis, A., Wolf, P., & Mameniškienė, R. (2026) · Epilepsia · doi:10.1002/epi.70248
“However, the overall reduction in symptoms of anxiety did not constitute a clinically meaningful improvement (with the threshold set at a reduction by 3–4 points), 34,35 likely owing to low baseline GAD-7 scores.”
Li, X., Yang, X., & Wang, X. (2026) · Medicine · doi:10.1097/md.0000000000048387
“[23,24] The GAD-7 is a self-reported anxiety questionnaire consisting of 7 items.”
Gillen, L., Nguyen, E. V., Dodd, S., Irving, T., Tan, A., Boyne, E., Hartung, K., Olaithe, M., Bucks, R. S., Ree, M. J., et al. (2026) · Behaviour Research and Therapy · doi:10.1016/j.brat.2026.105048
Rand, K., Menichetti, J., Wisløff, T. F., & Brorson, H. H. (2026) · JMIR Research Protocols · doi:10.2196/84096
Intranasal Ketamine for Existential Distress in Advanced Cancer
Aguiar, S., Makarious, M., Lipsitz, O., deVries, F. E., Doyle, Z., McIntyre, R. S., Rodin, G., Zimmermann, C., Mak, E., Hannon, B. L., et al. (2026) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2026.04.611 · Cited by 1
Ding, P., & Wang, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1826577
“Anxiety symptoms were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7)(26), which evaluates the frequency of anxiety-related symptoms over the past 2 weeks, including nervousness, inability to control worry, excessive worry, difficulty relaxing, restlessness, irritability, and fear that something awf…”
InfluentialMark, T. L., Saavedra, L. M., Kirsch, S., Pogue, Y. Z., Lynch, F. L., Koebnick, C., Morgan‐López, A. A., Yaros, A., & Juel, E. K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-119157
“…both adult and adolescent populations 23 24 ; (2) it is responsive to change and thus can be used to measure progress in reducing anxiety symptoms, 25 and (3) it is feasible to implement at scale because it is brief and as evidenced by the fact that it is already used widely in US health systems,…”
Huang, W., Wu, Y., Shen, Y., Song, H., Chen, Y., Lin, R., Wang, Y., & Yang, X. H. (2026) · Healthcare · doi:10.3390/healthcare14101325 · Cited by 1
“The mean reduction in GAD-7 scores for the peer-counselor group (3.57 points in ITT, 3.96 in PP) approached or met the threshold for a minimally clinically important difference (MCID) of approximately 3–4 points [47].”
InfluentialBeyond the Inflammation: Integrating Mental Health Into Rheumatic Disease Care
Lin, Y., Chen, Y., Lee, Y., & Hung, C. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70689
Sun, Y., Huang, S., Chen, Y. C., Zhang, Q., & Zhang, Y. (2026) · Perspectives In Psychiatric Care · doi:10.1155/ppc/5276137
Clinical profile of headache attributed to anxiety and depressive disorders: an observational study
Chen, B., Zhang, S., Yang, J., Yan, X., Wang, C. C., & Wan, D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1805261
Ye, C., Wang, Y., Liu, Y., Zhu, W., Dai, M., Wang, L., Xu, Y., Li, L., Liu, Z., Ni, L., et al. (2026) · Gastroenterology report · doi:10.1093/gastro/goag024
“By answering each question, a total score ranging from 0 to 21 can be obtained, which is used to determine the severity of anxiety, from none or mild to severe [18].”
Research Progress on the Bidirectional Association between Periodontitis and Anxiety/Depression
林, 哲. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651977
Psychological responses to follow-up ultrasound in pregnant women with benign adnexal masses
Qiu, P.-X., & Sun, J. (2026) · Medicine · doi:10.1097/md.0000000000048906
“[19] A total score of >5 was considered indicative of mild anxiety symptoms.”
Gallois, C. B., Machado, M. M., Foppa, G. T., de Oliveira, R. A. L., de Baumont, A. C., Ebert, A. B., Zanelatto, L. A., Rangel, C. C., Lodi, B., dos Santos, L. R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9727754/v1
Zhang, B., Dai, Q., Huang, F., & Lv, J. (2026) · International Journal of Clinical and Experimental Medicine · doi:10.62347/lulg5831
Evaluating the Impact of a National Telehealth Outpatient Mental Health Program in Rural Communities
Auerbach, M. M., O'Neill, C., George, K., Summers, E., & O’Callaghan, E. (2026) · Healthcare · doi:10.3390/healthcare14111557
“Measure-specific MCID for PHQ-9 was defined as a >5-point reduction in scores and GAD-7 as >4-point reduction, consistent with prior research examining MCID in anxiety [23].”
Kelly, C. M., Fradet, M., Bostian, C. M., Donnelly, A. J., Ellis, S., Ostacher, M. J., Aaronson, S., & Suppes, T. M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122063
李, 晓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662254
Segawa, V. K., Nakano, J. M. T., Blaas, I. K., & Castaldelli-Maia, J. M. (2026) · Medicina Clínica y Social · doi:10.52379/mcs.v10.805
Wiginton, J. M., Xu, H., Tian, J. L. H., Xue, Q., Baral, S., Sanchez, T. H., & Murray, S. M. (2026) · International Journal of Social Psychiatry · doi:10.1177/00207640261456760
“…we documented, though statistically significant, were below commonly used thresholds indicative of clinical significance (Bischoff et al., 2020; Toussaint et al., 2020), though they do reflect findings from other longitudinal studies tracking anxiety during the early months of the pandemic…”
Imagery rescripting for generalized anxiety disorder: A case series
Stavropoulos, L., Phipps, A. B., Sabel, I., Cooper, D. D. J., Briggs, N., Newby, J. M., & Grisham, J. R. (2026) · British Journal of Clinical Psychology · doi:10.1111/bjc.70073
Leng, L. L., Xiao, W., He, X., Wang, T., & Ning, K. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10694
Engagement and Outcomes Associated With Message-Based Psychotherapy Among Older and Younger Adults
Renn, B. N., Peake, E. E., Brody, L. A., Padmanabhan, A., & Raue, P. J. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.06.016
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
Aggarwal, A., Erridge, S., Varadpande, M., Clarke, E., McLachlan, K., Coomber, R., Asghar, M., Bhoskar, U., Crews, M., Angelis, A. D., et al. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70146
Joint Effects of Early Pandemic Containment Policies on Anxiety in the United StatesPreprint
Watts, D., Khadse, P. N., Ebrahimi, O. V., Tubbs, J. D., Lian, J., Dall’Aglio, L., Fatori, D., Zhou, Y., Zuccolo, P. F., Cudic, M., et al. (2026) · medRxiv · doi:10.64898/2026.06.29.26356856
Graham, J. (2026) · Journal of EMDR Practice and Research · doi:10.34133/jemdr.0039
Metadata
- Authors
- Toussaint, A., Hüsing, P., Gumz, A., Wingenfeld, K., Härter, M., Schramm, E., & Löwe, B.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Charité – Universitätsmedizin Berlin (DE)
- University of Freiburg (DE)
- Corresponding author
- Toussaint, Anne
- ORCID
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 265
- Pages
- 395-401
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W3000661394
- Cited by
- 641
- References
- 68
- Citations by year
- 2026: 134 · 2025: 138 · 2024: 113 · 2023: 99 · 2022: 68 · 2021: 59 · 2020: 30
- FWCI
- 61.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- GAD-7, Generalized Anxiety Disorder Scale, anxiety symptoms, chronic depression, sensitivity to change, minimal clinically important difference, standardized response mean, treatment response monitoring, Hamilton Depression Rating Scale
- MeSH terms
- Minimal Clinically Important Difference, Patient Health Questionnaire, Anxiety Disorders, Depression, Humans, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review